Evidence map›Paper›PMID 31315227›Full record

ReviewNutrients2019

Gut Microbiome: Profound Implications for Diet and Disease.

Ronald D Hills, Benjamin A Pontefract, Hillary R Mishcon, Cody A Black, Steven C Sutton, Cory R Theberge

4 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 586 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
586citing papers in PubMed, 7 pooled it
38.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06030999 nacompletednot on this mapstarted 2023, after this paper: background citation

Three Arms, Randomized, Double-blind Controlled Trial Of Prevention And Treatment On Obesity And Weight Management By Oral Supplementation Of Probiotics And Prebiotics

TypeinterventionalSponsorShenzhen Precision Health Food Technology Co. Ltd.,Ran2023 to 2023Enrolled150ConditionsOverweight and ObesityArmsStudy product A (Wonderlab wonder4shape), Study product B (Wonderlab wonder4shape), Study product C (placebo)
NCT06107933 recruitingnot on this mapstarted 2023, after this paper: background citation

Developmental Impacts of MicroPLastics Exposure in Early Life

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2023 to 2027Enrolled40ConditionsInfant Development, Breast Feeding, Environmental ExposureArmsObservational only
NCT06158152 narecruitingnot on this mapstarted 2024, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Systemic Effect on Immunoinflammatory and Metabolic Status of an Oral Supplementation With AM3 in Patients With Metabolic Syndrome.

TypeinterventionalSponsorIndustrial Farmacéutica Cantabria, S.A.Ran2024 to 2026Enrolled48ConditionsMetabolic SyndromeArmsAM3 + Probiotic, Placebo, AM3
NCT07653698 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of Cancer Cachexia and Analysis of Gut Microbiota in Patients With Breast Cancer Receiving Home Care

TypeinterventionalSponsorFondazione ANT Franco Pannuti ETSRan2026 to 2028Enrolled140ConditionsBreast Cancer, Cancer CachexiaArmsProbiotic Mixture, Placebo
3 · Its place in the literature

Who cites it

586 citing papers in PubMed, 7 syntheses or guidelines pooled it, 1,090 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Effects ofFrontiers in nutrition · 2025
    Pooled it
  6. Effects ofFrontiers in microbiology · 2025
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Modulatory Effects ofNutrients · 2026
    Article
  18. Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  19. Article
  20. Article

526 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ronald D HillsDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New England, Portland, ME 04103, USA. rhills@une.edu.ORCID 0000-0003-0352-0020
Benjamin A PontefractPharmacy Service, Boise Veterans Affairs Medical Center, Boise, ID 83702, USA.
Hillary R MishconDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New England, Portland, ME 04103, USA.
Cody A BlackDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New England, Portland, ME 04103, USA.
Steven C SuttonDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New England, Portland, ME 04103, USA.ORCID 0000-0002-6349-0356
Cory R ThebergeDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New England, Portland, ME 04103, USA.
New England College · USFerris State University · US

Funding

American Foundation for Pharmaceutical Education Gateway to Research AwardNational Science Foundation MCB 1516826
6 · The paper itself

Abstract

The gut microbiome plays an important role in human health and influences the development of chronic diseases ranging from metabolic disease to gastrointestinal disorders and colorectal cancer. Of increasing prevalence in Western societies, these conditions carry a high burden of care. Dietary patterns and environmental factors have a profound effect on shaping gut microbiota in real time. Diverse populations of intestinal bacteria mediate their beneficial effects through the fermentation of dietary fiber to produce short-chain fatty acids, endogenous signals with important roles in lipid homeostasis and reducing inflammation. Recent progress shows that an individual's starting microbial profile is a key determinant in predicting their response to intervention with live probiotics. The gut microbiota is complex and challenging to characterize. Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the relative abundance of beneficial genera (e.g.,

Indexed as

DietGastrointestinal MicrobiomeBacteriaBiomarkersGastrointestinal DiseasesHumansBiomarkerscardiometabolic risk factorschronic health conditionsgastrointestinal disordersgut microbiotahabitual dietsnutritionobesityprebiotics and probioticsWestern diet

Identifiers

PMID31315227
PMCPMC6682904
OpenAlexW2957585395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.